Possibility of the Heart Rate Variability Correction with a High Dose of Omega-3-polyunsaturated Fatty Acids in Patients with Acute Myocardial Infarction and Concomitant Type 2 Diabetes Mellitus

CLINICAL RESEARCH
Aleksey G. Nikishin, MD, ScD; Timur A. Nurbaev, MD; Maksud S. Khasanov, MD; Saodat Y. Abdullaeva, MD; Nodirbek T. Yakubbekov, MD

The Republican Specialized Center of Cardiology. Tashkent, Uzbekistan

*Corresponding author: Aleksey G. Nikishin, MD, ScD.Republican Specialized Center of Cardiology, 4, Osiyo str., 100052. Tashkent, Uzbekistan. E-mail: angdoc@yandex.ru

Published: September 20, 2014.

Abstract: 

Aim: To evaluate the efficacy of a high dose (4g/day) of omega-3-PUFA on the heart rate variability (HRV) characteristics in patients with acute myocardial infarction (AMI) and Type 2 Diabetes Mellitus (T2DM).

Material and Methods: The study included 93 patients with AMI and concomitant T2DM during the first 48 hours from the onset of the disease. Group 1 comprised 40 patients, who received the standard therapy for AMI. Group 2 consisted of 53 patients, who, in addition to the standard treatment, in the absence of contraindications received omega-3-PUFA (4g/day) from the first day of therapy.  All patients underwent Holter ECG monitoring on the first and seventh days of hospitalization.

Results: In the first 48 hours of AMI, a strong trend in reduction of SDNN value in the daytime and at night was marked in patients of both groups.  There were no significant changes in HRV time-domain indicators during standard therapy in Group 1. In contrast, Group 2 was characterized by statistically significant increases in mRR and SDNN values in the daytime, as well as RMSSD and pNN50%. This trend was also observed at night.  In Group 2, Mo and HRV TI (in daytime and at night) also changed significantly compared to baseline.

Conclusion: In the patients with AMI and concomitant T2DM, there were significant changes in the main parameters of HRV that reflected the decrease in the activity of the parasympathetic nervous system and an increase in the activity of the sympathetic nervous system. Use of omega-3-PUFA in addition to standard therapy from the first hours of AMI allowed stabilization of the parasympathetic-sympathetic imbalance.

Keywords: 
acute myocardial infarction; type 2 diabetes mellitus; omega-3-polyunsaturated fatty acids.
References: 
  1. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996; 17(3):354–81.
  2. Yavelov IS, Deev AD, Travina EE, Gracianskiy NA. Prognostic value of the mean frequency of contractions and heart rate variability assessed for short time under the standard conditions at the early terms of myocardial infarction. Russ Cardiol J 1999; 6:6-13.[Article in Russian].
  3. Kiryachkov YY, Khmelevskiy YM, Voroncova EV. Computed analysis of heart rate variability: technique, interpretation, clinical use. Anaesthesiology J 2000; (2):56-62. [Article in Russian].
  4. Yavelov IS, Zuykov YA, Deev AD, Travina EE, Gracianskiy NA, Averkov OV, Vaulin NA. Experience of study on heart rate variability in acute coronary syndromes. Russ Cardiol J 1999; (1):3-10. [Article in Russian].
  5. Derad L, Otterbein A, Molle M, Petrowsky R, Born J, Fehm H. The angiotensin converting enzyme inhibitors fosinopril and enalapril differ in their central nervous effects in humans.  J Hypertens 1996; 14(11):1309-1315.
  6. Dmitryuk PB. Effect of propafenon on the dynamics of rhythmographic parameters and quality of life in the patients with extrassystolic arrhythmia. Russ Cardiol J 1997; 37(3): 47-50. [Article in Russian].
  7. GISSI-Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico). Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999; 354(9177):447-55.
  8.  Singer DH, Ori Z. Changes in heart rate variability associated with sudden cardiac death. In: Malik M, Camm AJ, Eds. Heart rate variability. Armonk, NY: Future Publishing Co 1995:429-48.
  9. Binkley PF, Haas GJ, Starling RC, Nunziata E, Hatton PA, Leier CV, et al. Sustained augmentation of parasympathetic tone with angiotensin- converting enzyme inhibition in patients with congestive heart failure. J Am Coll Cardiol 1993; 21(3):655-61.
  10. Bigger JTJr, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992; 85(1):164-71.
  11. Guzzetti S, Dassi S, Pecis M, Casati R, Masu AM, Longoni P,  et al. Altered pattern of circadian neural control of heart period in mild hypertension. J Hypertens 1991; 9(9):831-8.
  12. Binkley PF, Nunziata E, Haas GJ, Nelson SD, Cody RJ. Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. J Am Coll Cardiol 1991; 18(2):464-72.
  13. Townend JN, West JN, Davies MK, Littles W.A. Effect of quinapril on blood pressure and heart rate in congestive heart failure. J Am Cardiol 1992; 69(19):1587-90.
  14. Burr M.L. Reflections on the diet and reinfarction trial (DART). Eur Heart J 2001; 3(suppl D):75-78.
  15. Corr PB, Yamada KA, Witkowski FX. Mechanisms controlling cardiac autonomic function and their relation to arrhythmogenesis. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, Eds. The Heart and Cardiovascular System. New York: Raven Press; 1986:1343-1404.
  16. Levy MN, Schwartz PJ, Eds. Vagal control of the heart: Experimental basis and clinical implications. Armonk, NY: Future Publishing Co; 1994.
  17. Schwartz PJ, Priori S.G. Sympathetic nervous system and cardiac arrhythmias. In: Zipes DP, Jalife J, Eds. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, PA:  WB Saunders Company; 1990:330-343.
  18. Lanza G.A, Pedrotti P, Rebuzzi AG, Pasceri V, Quaranta G, Maseri A. Usefulness of the addition of heart rate variability to Holter monitoring in predicting in-hospital cardiac events in patients with unstable angina pectoris. Am J Cardiology 1997; 80(3):263-7.
  19. McCance AJ, Thompson PA, Forfar JC. Increased cardiac sympathetic nervous activity in patients with unstable coronary heart disease. Eur Heart J 1993;14(6):751-7. 

The fully formatted PDF version is available.

Download Article

Int J Biomed. 2014; 4(3):138-142. © 2014 International Medical Research and Development Corporation. All rights reserved.